Key statistics
On Monday, Tourmaline Bio Inc (TRML:NSQ) closed at 26.66, 190.41% above the 52 week low of 9.18 set on Oct 23, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 26.59 |
---|---|
High | 27.10 |
Low | 26.11 |
Bid | 26.00 |
Offer | 27.20 |
Previous close | 26.73 |
Average volume | 371.69k |
---|---|
Shares outstanding | 25.64m |
Free float | 19.84m |
P/E (TTM) | -- |
Market cap | 685.39m USD |
EPS (TTM) | -2.54 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 21:00 BST.
More ▼
Announcements
- Tourmaline Bio to Present at Upcoming Investor Conferences
- Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
- Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer
- Tourmaline Bio to Present at the Jefferies Global Healthcare Conference
- Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
- Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
- Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- Tourmaline Bio Announces Pricing of Public Offering of Common Stock
More ▼